167 related articles for article (PubMed ID: 34186155)
21. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
Micklem KJ; Sim RB; Sim E
Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
[TBL] [Abstract][Full Text] [Related]
22. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes.
Thornton BP; Vĕtvicka V; Ross GD
J Immunol; 1994 Feb; 152(4):1727-37. PubMed ID: 8120381
[TBL] [Abstract][Full Text] [Related]
23. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.
Kremlitzka M; Polgár A; Fülöp L; Kiss E; Poór G; Erdei A
Int Immunol; 2013 Jan; 25(1):25-33. PubMed ID: 22962438
[TBL] [Abstract][Full Text] [Related]
24. [Role of the complement C3 protein in the control of the specific immune response].
Villiers CL; Villiers MB; Marche PN
Ann Biol Clin (Paris); 1999; 57(2):127-35. PubMed ID: 10210739
[TBL] [Abstract][Full Text] [Related]
25. Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men.
Erdei A; Lukácsi S; Mácsik-Valent B; Nagy-Baló Z; Kurucz I; Bajtay Z
Semin Cell Dev Biol; 2019 Jan; 85():110-121. PubMed ID: 29174917
[TBL] [Abstract][Full Text] [Related]
26. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).
Hannan JP
Curr Protein Pept Sci; 2016; 17(5):463-87. PubMed ID: 26916158
[TBL] [Abstract][Full Text] [Related]
27. Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
Tuveson DA; Ahearn JM; Matsumoto AK; Fearon DT
J Exp Med; 1991 May; 173(5):1083-9. PubMed ID: 1708808
[TBL] [Abstract][Full Text] [Related]
28. Regulation of B-cell activation by complement receptors CD21 and CD35.
Erdei A; Prechl J; Isaák A; Molnár E
Curr Pharm Des; 2003; 9(23):1849-60. PubMed ID: 12871189
[TBL] [Abstract][Full Text] [Related]
29. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan.
Yan J; Vetvicka V; Xia Y; Hanikýrová M; Mayadas TN; Ross GD
Immunopharmacology; 2000 Jan; 46(1):39-54. PubMed ID: 10665778
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of complement receptors CR1/2 and CR4 by murine M1 and M2 macrophages.
Ghate A; Sharma S; Agrawal P; Sahu A
Mol Immunol; 2021 Sep; 137():75-83. PubMed ID: 34229135
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
[TBL] [Abstract][Full Text] [Related]
32. The complement fragment C3d facilitates phagocytosis by monocytes.
Gaither TA; Vargas I; Inada S; Frank MM
Immunology; 1987 Nov; 62(3):405-11. PubMed ID: 3499379
[TBL] [Abstract][Full Text] [Related]
33. Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.
Mácsik-Valent B; Nagy K; Fazekas L; Erdei A
Front Immunol; 2019; 10():1493. PubMed ID: 31312202
[TBL] [Abstract][Full Text] [Related]
34. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
Donius LR; Weis JH
Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
[TBL] [Abstract][Full Text] [Related]
35. Functional studies of chronic lymphocytic leukemia B cells expressing β
Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A
Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901
[TBL] [Abstract][Full Text] [Related]
36. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
Leslie RG; Prodinger WM; Nielsen CH
Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
[TBL] [Abstract][Full Text] [Related]
37. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
[TBL] [Abstract][Full Text] [Related]
38. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional relationships among receptors and regulators of the complement system.
Dierich MP; Schulz TF; Eigentler A; Huemer H; Schwäble W
Mol Immunol; 1988 Nov; 25(11):1043-51. PubMed ID: 2975757
[TBL] [Abstract][Full Text] [Related]
40. Mucosal type mast cells express complement receptor type 2 (CD21).
Andrásfalvy M; Prechl J; Hardy T; Erdei A; Bajtay Z
Immunol Lett; 2002 Jun; 82(1-2):29-34. PubMed ID: 12008031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
